Rehovot, Israel

Hagit Amitai



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hagit Amitai - Innovator in Recombinant Protein Technology

Introduction

Hagit Amitai is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein expression. His innovative approaches have the potential to enhance the efficiency and effectiveness of protein production in mammalian systems.

Latest Patents

Hagit Amitai holds a patent for a method aimed at improving the homogeneity and secretion of recombinant proteins expressed in mammalian cells. The patent, titled "Homogeneity and secretion of recombinant proteins in mammalian systems," focuses on replacing the endogenous signal peptide sequence of the DNA encoding the protein of interest with that of human hGH. Specifically, this invention pertains to a method where the protein of interest is a subunit of the follicle stimulating hormone (FSH). The invention also includes DNA expression vectors that contain the sequence encoding such proteins fused to the signal peptide sequence of hGH, as well as cells that harbor these vectors. He has 1 patent to his name.

Career Highlights

Throughout his career, Amitai has worked with prominent companies in the biotechnology sector. Notable among these are Applied Research Systems and Merck Serono S.A. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the field.

Collaborations

Amitai has collaborated with several professionals in his field, including Edith Chitlaru and Daniel Helman. These collaborations have likely enriched his research and development efforts, fostering a productive exchange of ideas and expertise.

Conclusion

Hagit Amitai's contributions to recombinant protein technology exemplify the impact of innovation in biotechnology. His patent and collaborations reflect a commitment to advancing scientific knowledge and improving biopharmaceutical production methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…